SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

78,094.64 166.49
( 0.21%)

Global Indices

Nasdaq

52,226.10 610.96
(1.18%)

Dow Jones

7,460.10 122.95
(1.68%)

Hang Seng

64,316.33 2,448.90
(3.96%)

Nikkei 225

10,886.26 -22.15
(-0.20%)

Forex

USD-INR

95.69 -0.03
(-0.03%)

EUR-INR

109.15 0.26
(0.24%)

GBP-INR

127.35 0.13
(0.10%)

JPY-INR

0.58 0.00
(0.09%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Procter & Gamble Health Ltd

Industry : Pharmaceuticals - Multinational

BSE Code

ISIN Demat

Book Value()

500126

INE199A01012

316.0053682

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

PGHL

33.02

10793.75

EPS(TTM)

Face Value()

Div & Yield %

196.94

6.38

Back

Huhtamaki India standalone net profit rises 75.34% in the June 2026 quarter

Jul 21,2026

Net profit of Huhtamaki India rose 75.34% to Rs 43.73 crore in the quarter ended June 2026 as against Rs 24.94 crore during the previous quarter ended June 2025. Sales rose 23.09% to Rs 728.60 crore in the quarter ended June 2026 as against Rs 591.94 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	728.60	591.94	23
OPM %	10.31	7.19	-
PBDT	73.07	46.21	58
PBT	58.79	33.12	78
NP	43.73	24.94	75

78,094.64 166.49 ( 0.21%)

52,226.10 610.96 (1.18%)

7,460.10 122.95 (1.68%)

64,316.33 2,448.90 (3.96%)

10,886.26 -22.15 (-0.20%)

95.69 -0.03 (-0.03%)

109.15 0.26 (0.24%)

127.35 0.13 (0.10%)

0.58 0.00 (0.09%)